Complete Regression of Established Subcutaneous B16 Murine Melanoma Tumors after Delivery of an HIV-1 Vpr-Expressing Plasmid by in Vivo Electroporation
Authors:
- Kenneth E. UgenKUKenneth E. Ugen
- Karuppiah MuthumaniKMKaruppiah Muthumani
- J.J. KimJKJ.J. Kim
- David B. WeinerDWDavid B. Weiner
- Richard HellerRHRichard Heller
Open Access
- 1 November 2006
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 14 (5) , 647-655
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Regression of subcutaneous B16 melanoma tumors after intratumoral delivery of an IL-15-expressing plasmid followed by in vivo electroporationCancer Gene Therapy, 2006
- IL-12 Gene Therapy Using an Electrically Mediated Nonviral Approach Reduces Metastatic Growth of MelanomaDNA and Cell Biology, 2003
- Electrically mediated delivery of vector plasmid DNA elicits an antitumor effectGene Therapy, 2002
- IL-12 Plasmid Delivery by in Vivo Electroporation for the Successful Treatment of Established Subcutaneous B16.F10 MelanomaMolecular Therapy, 2002
- Antisense MBD2 gene therapy inhibits tumorigenesisThe Journal of Gene Medicine, 2002
- Intratumoral Delivery of Interleukin 12 Expression Plasmids with In Vivo Electroporation Is Effective for Colon and Renal CancerHuman Gene Therapy, 2001
- Plasmid DNA Vaccines: Investigation of Integration into Host Cellular DNA following Intramuscular Injection in MiceIntervirology, 2000
- In vivo gene delivery by electroporationAdvanced Drug Delivery Reviews, 1999
- In Vitro and In Vivo Tumor Growth Suppression by HIV-1 VprDNA and Cell Biology, 1997
- Human Immunodeficiency Virus: The Eighth GeneAIDS Research and Human Retroviruses, 1987